Natural History and Management of Flat and Polypoid Dysplasia in Inflammatory Bowel Disease

Gastroenterology Clinics of North America

Volumn 35, Issue 3, 2006, Pages 573-579

  Bernstein, Charles N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CARCINOMATOSIS; CECUM DISEASE; COLON RESECTION; COLORECTAL CANCER; DYSPLASIA; ENTERITIS; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; POLYPECTOMY; REVIEW; RISK REDUCTION; SWEDEN; TUMOR BIOPSY; ULCERATIVE COLITIS; UNITED KINGDOM;

COLITIS, ULCERATIVE; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; POPULATION SURVEILLANCE; PRECANCEROUS CONDITIONS;

EID: 33748113460     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2006.07.010     Document Type: Review

References (22)

1. Bernstein C.N., Shanahan F., and Weinstein W.M. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?. Lancet 343 (1994) 71-74
2. Connell W.R., Lennard-Jones J.E., Williams C.B., et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 107 (1994) 934-944
3. Eaden J., Abrams K.R., and Mayberry J.F. The risk of CRC in ulcerative colitis: a meta-analysis. Gut 48 (2001) 526-535
4. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 130 (2006) 1030-1038
5. Bernstein C.N. Low grade dysplasia in ulcerative colitis. Gastroenterology 127 (2004) 950-956
6. Rutter M., Saunders B., Wilkinson K., et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126 (2004) 451-459
7. Eaden J., Abrams K., Ekbom A., et al. Colorectal cancer prevention in ulcerative colitis: a case control study. Aliment Pharmacol Ther 14 (2000) 145-153
8. Van Staa T.P., Card T., Logan R.F., et al. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut 54 (2005) 1573-1578
9. Bernstein C.N., Metge C., Blanchard J.F., et al. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?. Am J Gastroenterol 98 (2003) 2784-2788
10. Lindberg B., Persson B., Veress B., et al. Twenty years' colonoscopic surveillance of patients with ulcerative colitis. Scand J Gastroenterol 31 (1996) 1195-1204
11. Ullman T.A., Loftus E.V., Kakar S., et al. The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol 97 (2002) 922-927
12. Ullman T.A., Croog T., Harpaz N., et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 125 (2003) 1311-1319
13. Itzkowitz S.H., and Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 126 (2004) 1634-1648
14. Lynch D.A.F., Lobo A.J., Sobala G.M., et al. Failure of colonoscopic surveillance in ulcerative colitis. Gut 34 (1993) 1075-1080
15. Lim D.H., Dixon M.F., Vail A., et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut 52 (2003) 1127-1132
16. Lindberg J., Stenling R., Palmqvist R., et al. Efficiency of colorectal cancer surveillance in patients with ulcerative colitis: 26 years experience in a patient cohort from a defined population area. Scand J Gastroenterol 40 (2005) 1076-1080
17. Blackstone M.O., Riddell R.H., Rogers B.H.G., et al. Dysplasia associated lesion or mass (DALM) detected by colonoscopy in long standing ulcerative colitis: an indication for colectomy. Gastroenterology 80 (1981) 366-374
18. Bernstein C.N., Weinstein W.M., Levine D.S., et al. Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol 90 (1995) 2106-2114
19. Engelsgjerd M., Farraye F., and Odze R.D. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 117 (1999) 1288-1294
20. Rubin P.H., Friedman S., Harpaz N., et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 117 (1999) 1295-1300
21. Bernstein C.N. ALMs versus DALMs in ulcerative colitis: polypectomy or colectomy?. Gastroenterology 117 (1999) 1488-1491
22. Odze R., Farraye F.A., Hecht J.L., et al. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2 (2004) 534-541